Analysis for iShares MSCI Brazil ETF
Analysis summary
iShares MSCI Brazil ETF (EWZ) currently has a total score of 53 points, placing it in the neutral range. The score is made up of Performance (41), Stability (56) and Trend (79). The profile is clearly uneven: Trend stands out while Performance is more neutral.
Performance scores 41 points (neutral). Key strength: 1Y return at 47.3 %. Weaker metric: 5Y return at 4.2 %. This points to a sharper upswing more recently.
Stability scores 56 points (neutral). Key strength: Sharpe ratio (90d) at 1.70. Weaker metric: max drawdown (10Y) at -76.3 %. That indicates very deep historical drawdowns. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 79 points (strong). Key strength: Price is about 23.0 % above SMA200. Even the weakest metric remains solid in absolute terms: trend strength at 0.84. That often means the move is strong, but not perfectly steady.
Overall, the picture is mixed: Trend does the heavy lifting while Performance holds the score back. On a metric level, Sharpe ratio (90d) stands out, while max drawdown (10Y) is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does iShares MSCI Brazil ETF fit best in FoxScore?
- iShares MSCI Brazil ETF fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
- How meaningful is the available history for iShares MSCI Brazil ETF?
- iShares MSCI Brazil ETF currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.